The first in ASTCT's new CAR T Webinar Series aired on June 9, 2021 with our speaker, Dr. Marcela Maus, and our moderator, Dr. Armin Ghobadi. This webinar, 'CAR T Basics and Biology' covered an overall review of CAR T Biology, the general process of generating CAR T, CAR T targets, the future directions of CAR T biology, and more!

This comprehensive slide library was developed by a group of clinicians that have been working together to create ongoing educational initiatives about CAR T therapy since 2017, and was most recently updated in 2023. The library covers several topics including: why CAR-T therapy, how CAR-T fits into the world of immuno-oncology, patient management, and institutional considerations. You have the option to download the full library, containing several modules, or you can download individual modules, as needed.

The ASTCT webinar, 'Off the Shelf CAR T: a deep dive,' aired on Thursday, October 13, 2022, at 2 PM CDT.

This webinar aired on July 28, 2021 at 1 PM CT for the third installment of the CAR T Webinar Series from ASTCT. This webinar featured a presentation by Dr. Scott Goldsmith, highlighting the key areas of CAR T vs. Transplant, including consultation, day to day management, sequential therapy, and the pros and cons of each. The webinar also included a robust panel discussion on these topics moderated by Dr. Tania Jain, and featuring Dr. Samantha Jaglowski, Dr. John DiPersio, Dr. Brian Hill, and Dr. Mazyar Shadman.

The ASTCT webinar, 'CAR T Manufacturing,' aired on August 25, 2022 at 1 PM CDT.

The second in ASTCT's CAR-T Webinar Series aired on June 29, 2021 at 2 PM CT with Dr. Frederick Locke, and our moderator, Dr. Akshay Sharma. This webinar, 'Clinical Advances in CAR T-Cell Therapy' covered a review of approved CAR-T products, practical aspects of referrals, eligibility, leukapheresis, and more!

This webinar is designed to provide participants an introduction and overview of hematopoietic cell transplantation (HCT). Topics during the presentation include: historical overview of hematopoietic cell transplantation (HCT); review of sources of hematopoietic stem cells utilized in HCT and their associated advantages and disadvantages; summary of the HCT process, including the evaluation of a potential patients, the execution of the HCT procedure itself and associated toxicities and complications; and list of important resources to aid healthcare professionals caring for HCT patients.

This webinar aired on August 30, at 2 PM CT and is the fourth installment of the CAR T Webinar Series from ASTCT. This webinar featured a presentation by Dr. Martina Pennisi, highlighting the key areas of CAR T toxicity management, including CRS/ICANS grading and management, as well as late post-infusion care. There was also a robust panel discussion on these topics moderated by Dr. Mariana Lucena, and featuring Dr. Shannon Maude, Dr. Sattva Neelapu, Dr. Yi Lin.

This webinar will focus on recent research in the use of hematopoietic cell transplant (HCT) and gene therapy as curative therapies for sickle cell disease (SCD), convening a panel of experts to explore patient eligibility, perceptions, and overcoming barriers to care. Many patients and providers alike are unfamiliar with HCT as a potential curative option for SCD patients, and there are many misperceptions as gene therapy gains more public attention. Demystifying transplant among SCD providers and elucidating inclusion and exclusion criteria for curative therapies can help physicians and families make informed treatment decisions. Encouraging discussion about HCT and gene therapy’s role in the treatment of SCD can help ensure that patients and providers can appropriately weigh their options, increasing access to curative care when appropriate.

These guidelines were published in the March 2020 edition of the BBMT Journal.